Braun J, Baraliakos X, Deodhar AA, et al. Secukinumab Demonstrates Low Radiographic Progression and Sustained Efficacy through 4 Years in Patients with Active Ankylosing Spondylitis. ACR 2017, abstract 3L.
Nieuwe EULAR- en GRAPPA-richtlijnen voor PsA: zoek de verschillen
feb 2017 | Arthritis psoriatica